SARC Talk SARC Trials

This episode showcases Dr. Albiruni Razak from the University of Toronto, Princess Margaret Cancer Center, and Dr. Neeta Somaiah from MD Anderson Cancer Center. Both experts bring a wealth of sarcoma knowledge, particularly focusing on well-differentiated and dedifferentiated liposarcoma. Dr. Razak and Dr. Somaiah delve into the complexities of diagnosing and treating liposarcoma, shedding light on the nuances of managing this rare type of cancer. Their discussion highlights the importance of multidisciplinary collaboration in providing the best care for patients. The
conversation also touches on the promising advancements in research, such as targeted therapies and immunotherapies. By sharing their expertise and insights, they aim to improve outcomes and quality of life for individuals facing this challenging disease.

This episode features SARC's CEO and President Steven Young. Steven speaks all about SARC, past, present, and future. In this episode, he shares insights into the challenges faced, the milestones achieved, and the values that have guided SARC through the years. Looking ahead, Steven paints a vivid picture of the exciting future that lies ahead for SARC. He discusses innovative projects, upcoming initiatives, and the organization's commitment to making a positive impact on the sarcoma community. 

This episode of SARC Talk features Dr. David Kirsch, MD, PhD, a Radiation Oncologist from the University of Toronto. In this episode, Dr. Kirsch sheds light on the vital role of radiation oncology in sarcoma, including clinical trial opportunities and the future of the field. Tune in for an insightful conversation that will deepen your understanding of the intersection between sarcoma and radiation oncology.

In this episode of SARC Talk, we are joined by Dr. Damon Reed from Memorial Sloan Cancer Center. Dr. Reed shares his insights on the current state of pediatric sarcoma research and the challenges that researchers face in the field. He also discusses the importance of tumor boards and how they can help to drive progress in sarcoma research. One of the highlights of our discussion is the development of the Evolutionary Tumor Board model. Dr. Reed explains how this model works and how it could help to accelerate the pace of discovery in the field.

This episode of SARC Talk features Dr. Jonathan Trent, MD, PhD. from the University of Miami Sylvester Comprehensive Cancer Center. Dr. Trent shares is knowledge on PEComas (perivascular epithelioid cell tumor), a rare soft tissue tumor. Take a listen and learn more about PEComas.

This episode of SARC Talk features Dr. Roberta Sanfilippo, MD from Instituto Nazionale Tumori in Milan, Italy. Dr. Sanfilippo shares her insights on mentorship, collaboration, and clinical trials in Europe. With her extensive research experience in liposarcoma, leiomyosarcoma, and uterine sarcoma, Dr. Sanfilippo brings a wealth of knowledge to the table.